Literature DB >> 29995206

Level of Alcohol Use Associated with HIV Care Continuum Targets in a National U.S. Sample of Persons Living with HIV Receiving Healthcare.

Emily C Williams1,2, Kathleen A McGinnis3, E Jennifer Edelman4, Theresa E Matson5,6, Adam J Gordon7,8, Brandon D L Marshall9, Kendall J Bryant10, Anna D Rubinsky11, Gwen T Lapham5,6, Derek D Satre12,13, Julie E Richards14,6, Sheryl L Catz15, David A Fiellin3,4, Amy C Justice3,4, Katharine A Bradley5,14,6,16,17.   

Abstract

We evaluated associations between levels of alcohol use and HIV care continuum components using national Veterans Aging Cohort Study data for all patients with HIV and AUDIT-C screening (2/1/2008-9/30/2014). Poisson regression models evaluated associations between alcohol use levels (non-drinking, low-, medium-, high-, and very high-level drinking) and: (1) engagement with care (documented CD4 cells/µl or viral load copies/ml labs), (2) ART treatment (≥ 1 prescription), and (3) viral suppression (HIV RNA < 500 copies/ml) within one year. Among 33,224 patients, alcohol use level was inversely associated with all care continuum outcomes (all p < 0.001). Adjusted prevalence of care engagement ranged from 77.8% (95% CI 77.1-78.4%) for non-drinking to 69.1% (66.6-71.6%) for high-level drinking. The corresponding range for ART treatment was 74.0% (73.3-74.7%) to 60.1% (57.3-62.9%) and for viral suppression was 57.3% (56.5-58.1%) to 38.3% (35.6-41.1%). Greater alcohol use is associated with suboptimal HIV treatment across the HIV care continuum.

Entities:  

Keywords:  Alcohol; Antiretroviral therapy; Care continuum; HIV; Treatment cascade; Viral suppression

Mesh:

Substances:

Year:  2019        PMID: 29995206      PMCID: PMC6344313          DOI: 10.1007/s10461-018-2210-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  41 in total

1.  Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.

Authors:  Derek D Satre; Alexandra N Anderson; Amy S Leibowitz; Tory Levine-Hall; Sally Slome; Jason Flamm; C Bradley Hare; Jennifer McNeely; Constance M Weisner; Michael A Horberg; Paul Volberding; Michael J Silverberg
Journal:  Contemp Clin Trials       Date:  2019-08-22       Impact factor: 2.226

2.  Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data.

Authors:  Derek D Satre; Varada Sarovar; Wendy Leyden; Charles B Hare; Sheryl L Catz; Kendall J Bryant; Emily C Williams; J Carlo Hojilla; Michael A Horberg; Michael J Silverberg
Journal:  AIDS Behav       Date:  2020-06

3.  Higher Levels of Alcohol Use Are Associated With Latent Tuberculosis Infection in Adults Living With Human Immunodeficiency Virus.

Authors:  Sarah B Puryear; Robin Fatch; Brian Beesiga; Allen Kekibiina; Sara Lodi; Kara Marson; Nneka I Emenyonu; Winnie R Muyindike; Dalsone Kwarisiima; Judith A Hahn; Gabriel Chamie
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

4.  Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.

Authors:  Benjamin J Oldfield; Kathleen A McGinnis; E Jennifer Edelman; Emily C Williams; Adam J Gordon; Kathleen Akgün; Stephen Crystal; Lynn E Fiellin; Julie R Gaither; Joseph L Goulet; P Todd Korthuis; Brandon D L Marshall; Amy C Justice; Kendall Bryant; David A Fiellin; Kevin L Kraemer
Journal:  J Subst Abuse Treat       Date:  2019-11-06

5.  Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.

Authors:  Madeline C Frost; Theresa E Matson; Judith I Tsui; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2018-10-30       Impact factor: 4.492

6.  Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial.

Authors:  E Jennifer Edelman; Stephen A Maisto; Nathan B Hansen; Christopher J Cutter; James Dziura; Yanhong Deng; Lynn E Fiellin; Patrick G O'Connor; Roger Bedimo; Cynthia L Gibert; Vincent C Marconi; David Rimland; Maria C Rodriguez-Barradas; Michael S Simberkoff; Janet P Tate; Amy C Justice; Kendall J Bryant; David A Fiellin
Journal:  J Subst Abuse Treat       Date:  2019-08-17

7.  Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV.

Authors:  Lauren Lipira; Deepa Rao; Paul E Nevin; Christopher G Kemp; Susan E Cohn; Janet M Turan; Jane M Simoni; Michele P Andrasik; Audrey L French; Joseph M Unger; Patrick Heagerty; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2019-11-20       Impact factor: 4.492

8.  A Modified Alcohol SBI for Use among Older Adults Living with HIV.

Authors:  Annie L Nguyen; Jordan E Lake; Diane Preciado; Diana Liao; Alison A Moore; Homero E Del Pino
Journal:  West J Nurs Res       Date:  2020-04-02       Impact factor: 1.967

9.  Alcohol Use and Antiretroviral Adherence Among Patients Living with HIV: Is Change in Alcohol Use Associated with Change in Adherence?

Authors:  Emily C Williams; Kathleen A McGinnis; Anna D Rubinsky; Theresa E Matson; Jennifer F Bobb; Gwen T Lapham; E Jennifer Edelman; Derek D Satre; Sheryl L Catz; Julie E Richards; Kendall J Bryant; Brandon D L Marshall; Kevin L Kraemer; Stephen Crystal; Adam J Gordon; Melissa Skanderson; David A Fiellin; Amy C Justice; Katharine A Bradley
Journal:  AIDS Behav       Date:  2021-01

10.  A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV-HCV Co-infection Who Drink Alcohol.

Authors:  Michael D Stein; Debra S Herman; H Nina Kim; Abigail Howell; Audrey Lambert; Stephanie Madden; Ethan Moitra; Claire E Blevins; Bradley J Anderson; Lynn E Taylor; Megan M Pinkston
Journal:  AIDS Behav       Date:  2020-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.